Got a question?
We'd love to chat with you.
Please do not hesitate to give us a call (or text) at (646) 360-0608.
~ Morgan & Kyle. Options MD Founders
You have options.
We understand severe and treatment-resistant depression can leave a person feeling like there isn’t anything that will help. The great news: there are over 200 treatments for depression, and our team of psychiatric experts are equipped to work with you on determining the best and most appropriate treatment.
Are you "treatment resistant"?
Roughly 1 in 3 people with depression are deemed “treatment resistant,” meaning 2 or more medications haven’t been effective in treating their depression. 1 If finding the right treatment for managing depression has been difficult, you’re in the right place.
How it works:
- 1
Build your profile.
First, fill out our free screener to see if you’re eligible for telemedicine through Options MD. We’ll assess your history with depression, symptoms, lifestyle, overall health, and personal treatment preferences.
- 2
Meet with experts.
Once accepted, you’ll be able to schedule a one-hour intake session so we can talk in depth about your individual care needs. Our psychiatric experts have 10+ years treating severe, treatment-resistant depression.
- 3
Access specialized treatment.
Get connected to one (or more) of the 200+ treatments in our toolkit including almost every antidepressant on the market, advanced behavioral treatments like EMDR, ACT, and DBT, and lifestyle changes.
I found [Options MD] to be really accessible in terms of being able to find what you need, being able to get to it, the language that was used, and the way that the research and the information was laid out.
Jesse
I’ve struggled with depression for over 15 years. I was starting to feel hopeless until I found Options MD. […] Their individualized approach to treatment helped steer me in the direction I needed to go to feel “normal” again.
Daniel
I've been struggling with depression for the better part of a decade, [...] I now have an appointment to speak with my provider regarding some of these options, and I'm excited and hopeful for the future.
Anna
Depression sucks.
We started a company to help people with severe and treatment-resistant depression get connected to the care they need. For that reason, our psychiatric experts have received additional training and board certification and have many years of experience in the management of long-term, complex cases.
Intake Session
1-Hour Consultation Meeting
$349149*Assess your history with depression, symptoms, lifestyle, overall health, and personal treatment preferences. You’ll leave with a diagnosis confirmation and personalized treatment plan.
*Discounted to $149 for first 30 patients with code: FIRST30
Therapy Follow-Up
Recurring Session
$112 each*
Receive personalized, evidence-based therapy like CBT, ACT, DBT, or EMDR that can be combined with other treatment approaches.
*Discounted packages available
Psych Follow-Up
Recurring Session
$112 each*
Optimize your treatment through close monitoring of your symptoms and management of side effects.
*Discounted packages available
Therapy Follow-Up
Recurring Session
$112 each*
Receive personalized, evidence-based therapy like CBT, ACT, DBT, or EMDR that can be combined with other treatment approaches.
*Discounted packages available
Intake Session
1-Hour Consultation Meeting
$349149*Assess your history with depression, symptoms, lifestyle, overall health, and personal treatment preferences. You’ll leave with a diagnosis confirmation and personalized treatment plan.
*Discounted to $149 for first 30 patients with code: FIRST30
Psych Follow-Up
Recurring Session
$112 each*
Optimize your treatment through close monitoring of your symptoms and management of side effects.
*Discounted packages available
Currently, all payments are out-of-pocket, but we are actively working on taking insurance. Stay tuned—we are planning to make this possible by 2023.
1 Ionescu DF, Rosenbaum JF, Alpert JE. Pharmacological approaches to the challenge of treatment-resistant depression. Dialogues Clin Neurosci. 2015;17(2):111-126. doi:10.31887/DCNS.2015.17.2/dionescu